The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary.


Journal

Expert review of hematology
ISSN: 1747-4094
Titre abrégé: Expert Rev Hematol
Pays: England
ID NLM: 101485942

Informations de publication

Date de publication:
03 2023
Historique:
entrez: 15 3 2023
pubmed: 16 3 2023
medline: 21 3 2023
Statut: ppublish

Résumé

The National Hemophilia Foundation State of the Science Research Summit initiative sought to unify research efforts in the US inherited bleeding disorders (BDs) community around key topics of importance to people living with inherited BDs, the lived experience experts. This community-led and -informed project focused on six broad areas - hemophilia A or B; von Willebrand Disease (VWD), platelet dysfunctions and other mucocutaneous inherited BDs; ultra-rare inherited BDs; the unique challenges of people with the potential to menstruate with inherited BDs; diversity, equity and inclusion, health services research, and implementation science; and facilitating research in the inherited BD community through designing an optimizied research infrastructure, enabling resources and funding, and furthering workforce capabilities required to execute the research priorities. The work summarized here, and in the accompanying supplement manuscripts , has implications not only for the US population but for people globally who have inherited BDs. The information is equally relevant to people living with hemophilia, VWD, the spectrum of inherited platelet disorders, ultra-rare factor deficiencies, and all other inherited BDs as it is to the health care providers and researchers focused on the care and treatment of inherited BDs in the US and globally.

Identifiants

pubmed: 36920857
doi: 10.1080/17474086.2023.2181782
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

129-134

Auteurs

Leonard A Valentino (LA)

National Hemophilia Foundation, New York, NY, USA.
Internal Medicine and Pediatrics, Rush University, Chicago, Illinois, USA.

Michelle L Witkop (ML)

National Hemophilia Foundation, New York, NY, USA.

Maria E Santaella (ME)

National Hemophilia Foundation, New York, NY, USA.

Donna DiMichele (D)

Donna DiMichele Consulting, LLC, Washington, DC, USA.
Department of Pediatrics, Weill Cornell Medical College, New York, New York, USA.

Michael Recht (M)

American Thrombosis and Hemostasis Network, Rochester, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH